Peer-reviewedCC BYDiagnostics (Basel, Switzerland)
Diagnostic Assessment of Tamoxifen-Associated Endometrial Pathology: A Narrative Review of Biomarkers, Risk Models, and Translational Gaps
Related
- Sepsis-associated endothelial dysfunction: clinical phenotypes, biomarkers, bedside evidence, and translational implications
- Non‐invasive biomarkers in biliary atresia: A scoping review of fibrosis assessment, translational readiness and clinical implementation gaps
- Diagnostic Performance of the Radiographic Assessment of Lung Edema Score for Acute Respiratory Distress Syndrome-Post Hoc Analysis of the "Validating Acute Lung Injury Biomarkers for Diagnosis" Study.
- Diagnostic accuracy of remote self-administered digital cognitive assessment by clinical diagnosis and Alzheimer's disease PET imaging biomarkers
- Identification of Neuroinflammation-Related Diagnostic Biomarkers in Metabolic Dysfunction-Associated Steatohepatitis: An Integrated Bioinformatics and Machine Learning Approach.
BibTeX
@article{anon2026diagnostic,
title = {{Diagnostic Assessment of Tamoxifen-Associated Endometrial Pathology: A Narrative Review of Biomarkers, Risk Models, and Translational Gaps}},
journal = {Diagnostics (Basel, Switzerland)},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13703038},
note = {CC BY},
}
RIS
TY - JOUR
TI - Diagnostic Assessment of Tamoxifen-Associated Endometrial Pathology: A Narrative Review of Biomarkers, Risk Models, and Translational Gaps
PY - 2026
DA - 2026/10/01
JO - Diagnostics (Basel, Switzerland)
UR - https://europepmc.org/article/PMC/PMC13703038
SN - 2075-4418
ER -